trending Market Intelligence /marketintelligence/en/news-insights/trending/dfqzvnbtbx4ug0q91dicnw2 content esgSubNav
In This List

Beijing Chunlizhengda director resigns; replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Beijing Chunlizhengda director resigns; replacement named

Beijing Chunlizhengda Medical Instruments Co., Ltd. said Cheung Kwan resigned as an independent nonexecutive director, effective March 16.

Cheung, who confirmed that he has no disagreement with the board, resigned due to the expiry of his service contract with the company.

The Chinese orthopedic medical device company appointed Ho Wai Ip as an independent nonexecutive director, also effective March 16.

Ip is a partner of Alliance & Associates certified public accountants and has entered into a service contract with the company for a term of three years.